Frequency of Chronic Obstructive Pulmonary Disease (COPD) Among Smokers and Non-Smokers at Hayatabad Medical Complex Peshawar
DOI:
https://doi.org/10.37762/jgnahs.126Keywords:
COPD, Smokers, Non-Smokers, Health-Related ProblemsAbstract
OBJECTIVES
The study aimed to determine the frequency of COPD, assess the severity of COPD and identify risk factors contributing to COPD development among smokers and non-smokers at Hayatabad Medical Complex.
METHODOLOGY
This cross-sectional study was done at Hayatabad Medical Complex Peshawar from April to December 2023. Data was collected from patients with COPD after obtaining consent, and an opinion poll was used to collect data about their symptoms and medical history. Data analysis was performed using SPSS 25. Chi-square and logistic regression analyses were conducted.
RESULTS
COPD prevalence was found to be significantly higher among smokers (45%) compared to non-smokers (10%) (p<0.001). Smokers exhibited greater severity of symptoms and lung function decline. Comorbid conditions like hypertension were also more frequent in smokers with COPD (30%) versus non-smokers with COPD (5%).
CONCLUSION
The frequency of COPD is more common in males and smokers, specifically those aged 46-60years and working in dirty environments, and most of them were presented with SOB and cough compared to non-smokers in which most of them were female and presented with chest tightness, acute bronchitis, and mucus.
References
Güldaval F, Polat G, Doruk S, Karadeniz G, Ayranci A, Türk M, et al. What are the Differences Between Smoker and Non-smoker COPD Cases? Is it a Different Phenotype? Turk Thorac J. 2021;22(4):284-8
Terzikhan N, Verhamme KM, Hofman A, Stricker BH, Brusselle GG, Lahousse L. Prevalence and incidence of COPD in smokers and non-smokers: the Rotterdam Study. Eur J Epidemiol. 2016;31(8):785-92
Salvi SS, Brashier BB, Londhe J, Pyasi K, Vincent V, Kajale SS, et al. Phenotypic comparison between smoking and non-smoking chronic obstructive pulmonary disease. Respir Res. 2020;21(1):50
Shameem M, Alam MA, Ahmad Z, Ejazi A. COPD in Non-smokers-Prevalence and Risk Factors. Br J Med Med Res. 2015;8(2):165-76
Backman H, Vanfleteren L, Lindberg A, Ekerljung L, Stridsman C, Axelsson M, et al. Decreased COPD prevalence in Sweden after decades of decrease in smoking. Respiratory research. 2020;21:1-12
Jiménez-Ruiz CA, Masa F, Miravitlles M, Gabriel R, Viejo JL, Villasante C, et al. Smoking characteristics: differences in attitudes and dependence between healthy smokers and smokers with COPD. Chest. 2001;119(5):1365-70
Sharman A, Zhussupov B, Sharman D, Stambekova A, Yeraliyev S. Cross-Sectional Study of Chronic Obstructive Pulmonary Disease Prevalence Among Smokers, Ex-Smokers, and Never-Smokers in Almaty, Kazakhstan: Study Protocol. JMIR Research Protocols. 2017;6(7):e7422
Kopitovic I, Bokan A, Andrijevic I, Ilic M, Marinkovic S, Milicic D, et al. Frequency of COPD in health care workers who smoke. Jornal Brasileiro de Pneumologia. 2017;43:351-6
Sexton P, Black P, Wu L, Sommerville F, Hamed M, Milne D, et al. Chronic obstructive pulmonary disease in non-smokers: a case-comparison study. COPD: Journal of Chronic Obstructive Pulmonary Disease. 2014;11(1):2-9
Lindberg A, Bjerg-Bäcklund A, Rönmark E, Larsson L-G, Lundbäck B. Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking: report from the Obstructive Lung Disease in Northern Sweden Studies. Respiratory medicine. 2006;100(2):264-72
van Durme YM, Verhamme KM, Stijnen T, van Rooij FJ, Van Pottelberge GR, Hofman A, et al. Prevalence, incidence, and lifetime risk for the development of COPD in the elderly: the Rotterdam study. Chest. 2009;135(2):368-77
Liu Y, Pleasants RA, Croft JB, Wheaton AG, Heidari K, Malarcher AM, et al. Smoking duration, respiratory symptoms, and COPD in adults aged≥ 45 years with a smoking history. International journal of chronic obstructive pulmonary disease. 2015:1409-16
Jha P, Chaloupka FJ. The impact of tobacco smoking on COPD. JAMA. 2019;291(24):2938-2939
World Health Organization. Global Burden of Disease 2019 Report. Geneva: WHO; 2020
GOLD Executive Committee. Global strategy for the diagnosis, management, and prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD); 2023
Ahmed R, Akhtar N, Ali N. Prevalence of COPD in Khyber Pakhtunkhwa: a regional analysis. Pak J Med Sci. 2021;37(5):1346-1350
Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet. 2009;374(9691):733-743
Lamprecht B, McBurnie MA, Vollmer WM, et al. COPD in never smokers: results from the population-based burden of obstructive lung disease study. Chest. 2011;139(4):752-763
Behera D, Balamugesh T. Biomass fuel smoke exposure as a risk factor for COPD. Eur Respir J. 2005;26(4):587-593
Siddiqui F, et al. Environmental risk factors for COPD in Pakistan. Respir Med. 2021;185:106489
Ahmed R, et al. Smoking and COPD: A hospital-based study in Karachi. Pak J Med Sci. 2020;37(7):1875-1881
Perez-Padilla R, Schilmann A, Riojas-Rodriguez H. Respiratory health effects of indoor air pollution. Int J Tuberc Lung Dis. 2010;14(9):1079-1086
Abubakar M, et al. Smoking and COPD: A hospital-based study in Pakistan. Chest. 2019;156(4):754-761
Siddiqui F, et al. Environmental risk factors for COPD in Pakistan. Respir Med. 2021;185:106489
Zafar M, Hussain W. Impact of smoking on lung function: a spirometric analysis. Pak J Med Sci. 2022;38(7):1875-1881
Singh D, et al. Impact of COPD on healthcare services in Pakistan. J Thorac Dis. 2023;15(5):1426-1435
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Shah Faisal, Zabih Ullah
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
